Junli Xue
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
-
- Aquaculture disease management and microbiota
- Invertebrate Immune Response Mechanisms
Papers in
-
- RNA modifications and cancer 5
- PI3K/AKT/mTOR signaling in cancer 4
- Ubiquitin and proteasome pathways 2
-
- Cancer, Hypoxia, and Metabolism 4
- Cancer-related molecular mechanisms research 3
- Co-authors
- Xing Jiang (1 shared paper)Yong Zhou (1 shared paper)Hua Wang (2 shared papers)Xinfeng Yan (2 shared papers)Xiaoxiao Ge (7 shared papers)Liqiong Xue (5 shared papers)Bo Feng (1 shared paper)Yipeng Ren (2 shared papers)
- Journals
- Journal of Clinical Oncology (6 papers)Cancer Letters (1 paper)npj Science of Food (1 paper)Fish & Shellfish Immunology (1 paper)European Heart Journal (1 paper)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Junli Xue
35 papers receiving 527 citations
Peers
Comparison fields: 5 of 80
- Cancer Research 182
- Immunology 85
- Molecular Biology 263
- Clinical Biochemistry 24
- Biochemistry 26
Countries citing papers authored by Junli Xue
This map shows the geographic impact of Junli Xue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junli Xue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junli Xue more than expected).
Fields of papers citing papers by Junli Xue
This network shows the impact of papers produced by Junli Xue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junli Xue. The network helps show where Junli Xue may publish in the future.
Co-authors
The 25 scholars most cited alongside Junli Xue, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 107 | |
| 2 | 2013 | 44 | |
| 3 | 2012 | 44 | |
| 4 | 2019 | 36 | |
| 5 | 2017 | 35 | |
| 6 | 2011 | 29 | |
| 7 | 2023 | 27 | |
| 8 | 2019 | 27 | |
| 9 | 2020 | 26 | |
| 10 | 2006 | 25 | |
| 11 | 2008 | 16 | |
| 12 | 2021 | 14 | |
| 13 | 2022 | 14 | |
| 14 | 2025 | 10 | |
| 15 | 2017 | 10 | |
| 16 | 2017 | 8 | |
| 17 | 2024 | 8 | |
| 18 | A bicistronic retroviral vector to introduce drug resistance genes into human umbilical cord blood CD34+ cells to improve combination chemotherapy tolerance. | 2001 | 7 |
| 19 | 2012 | 6 | |
| 20 | 2018 | 6 |
About Junli Xue
Junli Xue is a scholar working on Molecular Biology, Cancer Research, Oncology, Immunology and Radiology, Nuclear Medicine and Imaging, having authored 38 papers that have together received 533 indexed citations. Recurring topics across this work include RNA modifications and cancer (5 papers), PI3K/AKT/mTOR signaling in cancer (4 papers), Cancer, Hypoxia, and Metabolism (4 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Cancer, Stress, Anesthesia, and Immune Response (3 papers), Cancer-related molecular mechanisms research (3 papers), Genetic factors in colorectal cancer (3 papers) and Ubiquitin and proteasome pathways (2 papers). The work is most often cited by research in Cancer Research (182 citations), Immunology (85 citations), Molecular Biology (263 citations), Clinical Biochemistry (24 citations) and Biochemistry (26 citations). Junli Xue has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Xing Jiang, Yong Zhou, Hua Wang, Xinfeng Yan, Xiaoxiao Ge, Liqiong Xue, Bo Feng, Yipeng Ren, Wenjun Bu and Huanhuan Yang. Their work appears in journals such as Journal of Clinical Oncology, Cancer Letters, npj Science of Food, Fish & Shellfish Immunology and European Heart Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.